THERAPIX BIOSCIENCES LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • October 9th, 2020 • Therapix Biosciences Ltd. • Pharmaceutical preparations • New York
The undersigned, Therapix Biosciences Ltd., a company incorporated under the laws of Israel (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. The Underlying Ordinary Shares (as defined below) and Warrant Shares (as defined below) are to be deposited pursuant to a deposit agreement, as amended, dated March 21, 2017 (the “Deposit Agreement”), among the Company, The Bank of New York Mellon, as de
